Skip to content
Screener

Medtronic MDT Other Operating Segments — Other Nonrecurring (Income) Expense

Similar metrics at other companies

Sylvamo logo
SLVMEurope Segment — Other Nonrecurring (Income) Expense
$0
Celanese Corporation logo
CEOther — Other Nonrecurring (Income) Expense
$2M-33.3%
Voya Financial logo
VOYAInvestment Management Segment — Other Nonrecurring (Income) Expense
$27M+155%
Voya Financial logo
VOYAWealth Solutions Segment — Other Nonrecurring (Income) Expense
$3M-57.1%
Voya Financial logo
VOYAHealth Solutions Segment — Other Nonrecurring (Income) Expense
-$2M
Sylvamo logo
SLVMLatin America Segment — Other Nonrecurring (Income) Expense
$0-100%

Other financials

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$110.07B-3.9%
Enterprise value$137.33B-3.2%
P/E22.9×-1.6×
P/S-0.3×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp
FCF margin14.9%-0.5pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:OtherNonrecurringIncomeExpense.

The source filing: Medtronic’s 10-K, filed June 18, 2026.

Filed
Jun 18, 2026, 4:27 PM EDT
Fiscal year
FY2026
Accession
0001628280-26-044354
(in millions)CardiovascularNeuroscienceMedical SurgicalTotal
Net sales$13,976$10,287$8,815$33,079
Reconciliation of revenues
Other operating segments net sales(1)3,247
Other adjustments(2)39
Total consolidated net sales$36,364
Less:
Cost of products sold, excluding amortization of intangible assets4,6953,1513,47611,323
Research and development expense1,1366166862,438

Item 8. Financial Statements and Supplementary Data

FAQ

What is Medtronic's other operating segments — other nonrecurring (income) expense?
Medtronic (MDT) reported other operating segments — other nonrecurring (income) expense of -$9.75M in Q1 2026.
How has Medtronic's other operating segments — other nonrecurring (income) expense changed year-over-year?
Medtronic's other operating segments — other nonrecurring (income) expense decreased by 143.3% year-over-year, from $22.5M to -$9.75M.
What does other operating segments — other nonrecurring (income) expense mean?
This metric represents non-operating or irregular financial items within a specific business segment that are not expected to recur in the normal course of business. It captures one-time gains or losses, such as asset impairments, restructuring charges, or legal settlements, that impact the segment's profitability but are distinct from core operational performance.

Ask your AI about Medtronic's other operating segments — other nonrecurring (income) expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude